BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23892137)

  • 1. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
    Andey T; Patel A; Jackson T; Safe S; Singh M
    Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer.
    Ichite N; Chougule M; Patel AR; Jackson T; Safe S; Singh M
    Mol Cancer Ther; 2010 Nov; 9(11):3003-14. PubMed ID: 20978159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
    Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
    Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways.
    Cho SD; Yoon K; Chintharlapalli S; Abdelrahim M; Lei P; Hamilton S; Khan S; Ramaiah SK; Safe S
    Cancer Res; 2007 Jan; 67(2):674-83. PubMed ID: 17234778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
    Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
    Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.
    Lee SO; Andey T; Jin UH; Kim K; Singh M; Safe S
    Oncogene; 2012 Jul; 31(27):3265-76. PubMed ID: 22081070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 expression is induced by activation of nuclear nerve growth factor-induced Balpha (Nur77) in pancreatic cancer cells.
    Lee SO; Chintharlapalli S; Liu S; Papineni S; Cho SD; Yoon K; Safe S
    Mol Cancer Res; 2009 Jul; 7(7):1169-78. PubMed ID: 19584258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth.
    Cho SD; Lee SO; Chintharlapalli S; Abdelrahim M; Khan S; Yoon K; Kamat AM; Safe S
    Mol Pharmacol; 2010 Mar; 77(3):396-404. PubMed ID: 20023005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer.
    Ichite N; Chougule MB; Jackson T; Fulzele SV; Safe S; Singh M
    Clin Cancer Res; 2009 Jan; 15(2):543-52. PubMed ID: 19147759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.
    Chen C; Li Y; Hou S; Bourbon PM; Qin L; Zhao K; Ye T; Zhao D; Zeng H
    Microvasc Res; 2020 Mar; 128():103934. PubMed ID: 31654655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.
    Yoon K; Lee SO; Cho SD; Kim K; Khan S; Safe S
    Carcinogenesis; 2011 Jun; 32(6):836-42. PubMed ID: 21362629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells.
    Cho SD; Lei P; Abdelrahim M; Yoon K; Liu S; Guo J; Papineni S; Chintharlapalli S; Safe S
    Mol Carcinog; 2008 Apr; 47(4):252-63. PubMed ID: 17957723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
    Coxon A; Ziegler B; Kaufman S; Xu M; Wang H; Weishuhn D; Schmidt J; Sweet H; Starnes C; Saffran D; Polverino A
    Mol Cancer; 2012 Sep; 11():70. PubMed ID: 22992329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce apoptosis and inhibit renal cell carcinoma growth.
    York M; Abdelrahim M; Chintharlapalli S; Lucero SD; Safe S
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6743-52. PubMed ID: 18006776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through activation of c-jun N-terminal kinase.
    Lei P; Abdelrahim M; Cho SD; Liu S; Chintharlapalli S; Safe S
    Carcinogenesis; 2008 Jun; 29(6):1139-47. PubMed ID: 18460448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting NR4A1 (TR3) in cancer cells and tumors.
    Lee SO; Li X; Khan S; Safe S
    Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
    Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
    Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.
    Patel AR; Godugu C; Wilson H; Safe S; Singh M
    Pharm Res; 2015 Jul; 32(7):2292-300. PubMed ID: 25576245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.